BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/23/2021 7:48:08 AM | Browse: 730 | Download: 1362
 |
Received |
|
2021-04-27 20:50 |
|
Peer-Review Started |
|
2021-04-27 20:52 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-13 02:17 |
|
Revised |
|
2021-06-21 18:13 |
|
Second Decision |
|
2021-08-19 03:35 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-19 07:40 |
|
Articles in Press |
|
2021-08-19 07:40 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-08-31 04:08 |
|
Typeset the Manuscript |
|
2021-09-22 02:15 |
|
Publish the Manuscript Online |
|
2021-09-23 07:48 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Urotensin II levels in patients with inflammatory bowel disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Damir Alicic, Dinko Martinovic, Doris Rusic, Piero Marin Zivkovic, Ivana Tadin Hadjina, Marino Vilovic, Marko Kumric, Daria Tokic, Daniela Supe-Domic, Slaven Lupi-Ferandin and Josko Bozic |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Josko Bozic, MD, PhD, Associate Professor, Department of Pathophysiology, University of Split School of Medicine, Soltanska 2, Split 21000, Croatia. josko.bozic@mefst.hr |
| Key Words |
Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Urotensin II; Cardiovascular risk; Endoscopic activity |
| Core Tip |
Urotensin II (UII) is a potent vasoconstrictor with an immunomodulatory effect that is connected to various cardiovascular disorders. On the other hand, patients with inflammatory bowel disease (IBD) have increased cardiovascular burden as well as increased expression of UII receptors. It is plausible that UII is involved in the complex pathophysiology of IBD complications. In the current study, we investigated UII levels in the IBD population and compared it to matched control subjects, as well as connection of UII with relevant clinical and biochemical parameters. The results of this study showed that serum UII levels are higher in IBD patients in comparison with the control group. |
| Publish Date |
2021-09-23 07:48 |
| Citation |
Alicic D, Martinovic D, Rusic D, Zivkovic PM, Tadin Hadjina I, Vilovic M, Kumric M, Tokic D, Supe-Domic D, Lupi-Ferandin S, Bozic J. Urotensin II levels in patients with inflammatory bowel disease. World J Gastroenterol 2021; 27(36): 6142-6153 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i36/6142.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i36.6142 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
